HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Allelic homogeneity in Avellino corneal dystrophy due to a founder effect.

Abstract
Avellino corneal dystrophy (ACD) is a common corneal dystrophy that shows allelic homogeneity, R124H mutation in the transforming growth factor beta-induced (TGFBI) gene. There are distinct phenotypes of homozygous Avellino corneal dystrophy, termed types I and II. To investigate if the difference is caused by a modifier mutation, we sequenced the entire coding region of TGFBI of two types of ACDs. The sequences obtained from each type were identical, and we could not find any nucleotide alternations. Instead, we found seven single nucleotide polymorphisms (SNPs) compared with the normal control. Primer extension analysis revealed that all 14 homozygous patients were homozygotes in each SNP, which meant that all the patients shared the same disease haplotype. Subsequent analysis of 45 heterozygous ACD patients showed strong linkage disequilibrium between disease alleles of each SNP and ACD. These results strongly suggest that the allelic homogeneity of TGFBI associated corneal dystrophies (ACD, lattice corneal dystrophy types I and III, granular corneal dystrophy and Reis-Bucklers dystrophy) might not be caused by mutation hot spots but by the founder effects.
AuthorsKaoru Tsujikawa, Motokazu Tsujikawa, Hitoshi Watanabe, Naoyuki Maeda, Yoshitsugu Inoue, Takashi Fujikado, Yasuo Tano
JournalJournal of human genetics (J Hum Genet) Vol. 52 Issue 1 Pg. 92-97 ( 2007) ISSN: 1434-5161 [Print] England
PMID17096061 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Transforming Growth Factor beta1
Topics
  • Alleles
  • Base Sequence
  • Corneal Dystrophies, Hereditary (diagnosis, genetics)
  • DNA Mutational Analysis
  • Founder Effect
  • Haplotypes
  • Homozygote
  • Humans
  • Molecular Sequence Data
  • Mutation
  • Polymorphism, Single Nucleotide
  • Transforming Growth Factor beta1 (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: